Notable companies
The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN).
Industry description
The investment seeks long-term capital growth.
The Global Fund normally invests at least 40% of total assets in the equity securities of non-U.S. issuers throughout the world, which could include emerging market issuers, and may achieve its exposure to non-U.S. securities through investing in American depositary receipts (ADRs). The fund primarily owns common stock or securities convertible into common stocks. The fund is non-diversified.
Market Cap
The average market capitalization across the Longleaf Partners Global MF is 19.94B. The market cap for tickers in the group ranges from 251.49M to 80.46B. REGN holds the highest valuation in this group at 80.46B. The lowest valued company is CAN at 251.49M.
Volume
The average weekly volume growth across all stocks in the Longleaf Partners Global MF was -17%. For the same stocks of the MF, the average monthly volume growth was 31% and the average quarterly volume growth was -30%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 54
P/E Growth Rating: 31
Price Growth Rating: 51
SMR Rating: 71
Profit Risk Rating: 76
Seasonality Score: -26 (-100 ... +100)